Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months. 78% of subjects maintained a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback